LabMed

Prekallikrein Deficiency – Acquired

At a Glance

What Tests Should I Request to Confirm My Clinical Dx? In addition, what follow-up tests might be useful?

Acquired prekallikrein deficiency is very rare. It could arise from antibodies to the protein. There are few acquired inhibitors to prekallikrein reported. Its deficiency is not associated with bleeding.

Test results consistent with acquired prekallikrein deficiency include activated partial thromboplastin time (aPTT) that is mildly prolonged (35-45 seconds) with evidence on a mixing study or a specific prekallikrein inhibitor assay that something in the patient’s plasma can be transferred to normal plasma and produce the defect.(Table 1)

Table 1

Test Results Indicative of the Disorder
aPTT Low Prekallikrein Assay Mixing Study or Specific Inhibitor Assay
35-45 sec <10% Reveals an inhibitor to prekallikrein

Are There Any Factors That Might Affect the Lab Results? In particular, does your patient take any medications - OTC drugs or Herbals - that might affect the lab results?

Anticoagulants like heparin, enoxaparin, fondaparinux, hirudin, argatroban, bivalirudin, or dabigatran can interfere with any clot-based assay.

What Lab Results Are Absolutely Confirmatory?

Low prekallikrein assay with evidence of an inhibitor to prekallikrein on a mixing study is absolutely confirmatory.

Are There Any Factors That Might Affect the Lab Results? In particular, does your patient take any medications - OTC drugs or Herbals - that might affect the lab results?

Anticoagulants, high plasma lipids, and high serum bilirubin may affect lab results.

Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs

Sign Up for Free e-newsletters